Definium Therapeutics, Inc. (DFTX) bonds
DFTXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$32.08−0.92 (-2.79%)
Close on Nov 13, 2026Market cap $4.31BP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
Total debt
$36.66M
Long-term debt
Net debt
-$204.49M
After $241.15M of cash
Implied interest rate
17.56%
FY2025 interest ÷ average debt
Interest coverage
-30.3×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Notes and loans outstanding
Individual notes, bonds and loans
Definium Therapeutics's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
See a number that looks wrong?